Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > REGULATORY
REGULATORY
- Notification Calls for Revision of Package Inserts for Diabetes, MS Treatments
March 23, 2012
- Kawasaki’s Tonomachi District to Invite NIHS, Set to Become International Basis for R&D
March 23, 2012
- Eliminating Drug Lag Will Require Measures to Reduce “Application Lag”: Mr Akagawa of PFSB
March 22, 2012
- Council Meeting Considers Working Team to Explore Directions for Drug Distribution Improvement
March 21, 2012
- Pharmaceutical Industry Should be Fostered as “Core Industry Taxed Not Punished”: Mr Sengoku of DPJ
March 21, 2012
- CSIMC to Accelerate Discussions on Long-Listed Drugs, Cost-Benefit Assessments: Dr Suzuki of HIB
March 21, 2012
- Health Insurance Claims Services Releases 37 Additional Cases Based on “1980 Notice”
March 19, 2012
- Generics Not Listed in All Specifications to Be Delisted from April 1 with Some Exceptions
March 19, 2012
- MHLW Submits Application for Membership in PIC/S on March 9
March 19, 2012
- PMDA to Abolish Current Rule on Re-Employment of Its Former Employees
March 16, 2012
- Integration of Advanced Healthcare Service Systems “Not Related” to Compassionate Use System: Korosho
March 16, 2012
- Bill to Amend PAL Unlikely to Be Submitted in Current Diet Session Due to Time Constraints: Health Minister Komiyama
March 15, 2012
- Korosho Begins Discussions Toward Integrating Senshin-iryo, Kohdo-iryo Systems
March 15, 2012
- Dr Sakurai of PMDA Stresses Need for Japan’s Participation in PIC/S to Create Global Inspection System
March 14, 2012
- Dissolution of Gliclazide Tablets Attributed to Large Particle Size: Generic Drug Quality Study Group
March 13, 2012
- Convincing Data Needed to Perpetuate Premium for New Drug Development: Mr Yoshida of MED
March 13, 2012
- Gov’t Releases Some Documents Related to Draft Statement on Iressa Lawsuits
March 13, 2012
- MHLW Announces Requirements for “Clinical Research Core Hospitals”
March 12, 2012
- Study Group to Discuss Whether “ABC” Screening Should Be Included in Gastric Cancer Screening: Parliamentary Secretary Fujita
March 9, 2012
- DPJ’s PAL Subcommittee to Begin Compiling Recommendations in Mid-March; Timing of Bill Unclear
March 7, 2012
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…